H-LLIYDASNR-OH

Ref. 3D-PP48609

Informations sur le produit

• Nom: H-LLIYDASNR-OH

Description

Peptide H-LLIYDASNR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-LLIYDASNR-OH include the following: A validated LC-MS/MS method for the quantitation of daratumumab in rat serum using rapid tryptic digestion without IgG purification and reduction W Li, W Huang, X Yu, C Chen, Y Yuan, D Liu - of Pharmaceutical and , 2024 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0731708524001237 Pharmacokinetic analysis of a novel human EGFRvIII: CD3 bispecific antibody in plasma and whole blood using a high-resolution targeted mass spectrometry TH Schaller, MW Foster , JW Thompson - Journal of proteome , 2019 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.jproteome.9b00145 Integration of protein L-immobilized epoxy magnetic bead capture with LC-MS/MS for therapeutic monoclonal antibody quantification in serum R Cao, S Xu, Z Yu, L Xu, Z Ge, Q Huo, G Zhu - Analytical , 2024 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2024/ay/d4ay00433g Validated LC-MS/MS analysis of immune checkpoint inhibitor Nivolumab in human plasma using a Fab peptide-selective quantitation method: nano-surface N Iwamoto, T Shimada, H Terakado - Journal of Chromatography , 2016 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S157002321630277X Augmented clearance of nivolumab is associated with renal functions in chronic renal disease model rats K Taguchi, Y Hayashi, M Ohuchi, H Yamada - Drug Metabolism and , 2022 - ASPEThttps://dmd.aspetjournals.org/content/50/6/822.abstract

• Marque: Biosynth